相关实验视频

Updated: Jan 15, 2026

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

微调到下一代工程T细胞的微调

Tham T Nguyen¹, Patrick Ho², Sarah Staudt²

¹Laboratory of Hematology, GIGA, University of Liege, Liege, Belgium.

Nature biomedical engineering

|October 10, 2025

概括

化学抗原受体 (CAR) T细胞疗法对血液癌症有希望,但面临挑战. 工程CAR T细胞旨在克服下一代细胞疗法的这些障碍.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

化学抗原受体 (CAR) T细胞疗法对血液性恶性瘤有效.
临床使用揭示了T细胞功能和瘤微环境相互作用的挑战.
目前的战略重点是优化CAR T细胞产品以提高疗效.

研究的目的:

审查多方面的CAR T细胞工程方法.
突出下一代细胞疗法的新兴方向和战略.
为应对限制CAR T细胞治疗有效性的挑战.

主要方法:

转录基因和表观遗传学分析.
高通量功能选. 高通量的功能选.
基因编辑和传递技术.

主要成果:

确定新的标,结合剂和CAR T细胞增强机制.
开发克服T细胞功能障碍的策略.
工程技术的进步汽车T细胞产品.

结论:

卡尔-T细胞疗法需要持续的工程来克服内在和外在的挑战.
新的目标和先进的技术正在为改进的细胞疗法铺平道路.
继续研究CAR T细胞工程对于未来的临床成功至关重要.

更多相关视频

Production of Human CRISPR-Engineered CAR-T Cells

Production of Human CRISPR-Engineered CAR-T Cells

Published on: March 15, 2021

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

相关概念视频

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...